Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
IBBQInvescoINDEX

Invesco Nasdaq Biotechnology ETF

$34.92-2.13% vs prior close
273752-WK

Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

IBBQ price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DateIBBQ close
Aug 17, 2026$34.30
Aug 18, 2026$34.62
Aug 19, 2026$36.82
Aug 20, 2026$35.80
Aug 21, 2026$36.29
Aug 24, 2026$36.11
Aug 25, 2026$36.80
Aug 26, 2026$36.57
Aug 27, 2026$36.45
Aug 28, 2026$35.47
Aug 31, 2026$35.47
Sep 1, 2026$35.79
Sep 2, 2026$36.30
Sep 3, 2026$36.26
Sep 4, 2026$36.05
Sep 8, 2026$35.20
Sep 9, 2026$34.93
Sep 10, 2026$34.41
Sep 11, 2026$34.47
Sep 14, 2026$34.82
Sep 15, 2026$34.25
Sep 16, 2026$34.36
Sep 17, 2026$35.13
Sep 18, 2026$34.69
Sep 21, 2026$34.85
Sep 22, 2026$35.40
Sep 23, 2026$34.76
Sep 24, 2026$34.97
Sep 25, 2026$35.00
Sep 28, 2026$35.28
Sep 29, 2026$35.24
Sep 30, 2026$35.14
Oct 1, 2026$34.42
Oct 2, 2026$34.37
Oct 5, 2026$34.75
Oct 6, 2026$33.90
Oct 7, 2026$34.01
Oct 8, 2026$33.62
Oct 9, 2026$34.62
Oct 12, 2026$34.25
Oct 13, 2026$33.43
Oct 14, 2026$33.93
Oct 15, 2026$34.66
Oct 16, 2026$33.72
Oct 19, 2026$34.00
Oct 20, 2026$35.17
Oct 21, 2026$35.25
Oct 22, 2026$34.92
Oct 23, 2026$34.52
Oct 26, 2026$34.68
Oct 27, 2026$35.38
Oct 28, 2026$35.83
Oct 29, 2026$36.17
Oct 30, 2026$36.17
Nov 2, 2026$35.60
Nov 3, 2026$35.97
Nov 4, 2026$36.87
Nov 5, 2026$35.10
Nov 6, 2026$35.83
Nov 9, 2026$36.85
Nov 10, 2026$36.46
Nov 11, 2026$36.67
Nov 12, 2026$35.82
Nov 13, 2026$35.68
Nov 16, 2026$34.92

Weekly net flows, 3M

Net inflow over the range: +$45M

  • Inflow / above zero
  • Outflow / below zero
Aug 10Aug 17Aug 24Aug 31Sep 7Sep 14Sep 21Sep 28Oct 5Oct 12Oct 19Oct 26+$8.5MNov 2+$2.5MNov 9Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19+$8.5M+$2.5MNov 9Aug 10Sep 7Oct 5+$8.5M+$2.5MNov 9
Source: Daily creation and redemption records
Show as table
LabelValue ($)
Aug 10$1.4M
Aug 17$7.2M
Aug 24$4M
Aug 31$1.1M
Sep 7$1.1M
Sep 14$0
Sep 21$5.3M
Sep 28$6M
Oct 5$4.5M
Oct 12$1M
Oct 19$2.4M
Oct 26$0
Nov 2$8.5M
Nov 9$2.5M
The desk’s read

Money keeps arriving — +$13M of net inflows over the past month, about 10.4% of the fund's asset base, while the price has returned +23.0% so far this year. At 0.19% a year it is not the cheapest way in — XLV has a reported fee of 0.08%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$130Massets under management
0.19%expense ratio · $19 per $10,000 a year
+$13Mnet flow, trailing month
66Kavg daily volume, 30 days
246holdings · US-domiciled
2021listed June 11, 2021 · beta 0.84
The book at a glance
GILD-0.3%AMGN-0.7%VRTX-0.2%REGN-0.3%MRNA-3.6%BIIB-0.7%RVMD-3.1%RPRX-1.1%ILMN-4.4%ROIV-2.3%INSM+1.4%ARGX-0.9%UTHR-0.6%INCY-0.6%VTRS-0.4%ALNY-3.2%GH-5.1%MEDP-0.9%NBIX-1.2%ASND-1.3%EXEL-2.8%JAZZ-0.7%BBIO-1.2%ONC-1.3%TEM-9.6%HALO-3.8%SNY+0.0%KYMR-1.3%BNTXMDGLSMMT-16.5%PCVXKRYS

CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS

Holdings
#HoldingWeightPriceDay52-wk
1GILDGILEAD SCIENCES9.08%$167.58-0.3%
2AMGNAMGEN8.57%$462.32-0.7%
3VRTXVERTEX PHARMACEUTICALS7.82%$537.79-0.2%
4REGNREGENERON PHARMACEUTICALS6.25%$952.40-0.3%
5MRNAMODERNA5.77%$215.27-3.6%
6BIIBBIOGEN2.42%$251.65-0.7%
7RVMDREVOLUTION MEDICINES2.39%$166.87-3.1%
8RPRXROYALTY PHARMA2.00%$68.53-1.1%
9ILMNILLUMINA2.02%$198.00-4.4%
10ROIVROIVANT SCIENCES1.84%$38.61-2.3%
11INSMINSMED1.71%$122.88+1.4%
12ARGXARGENX SE1.62%$950.95-0.9%
13UTHRUNITED THERAPEUTICS1.64%$587.88-0.6%
14INCYINCYTE1.59%$120.27-0.6%
15VTRSVIATRIS1.55%$20.74-0.4%

The full book, free with one sign-in.

Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.

Sign in to see all 246

Sector weights

  • Healthcare100%
  • Health Technology97.86%
  • Commercial Services1.89%
  • Health Services0.23%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Healthcare100%
Health Technology97.86%
Commercial Services1.89%
Health Services0.23%

Country weights

  • United States94.97%
  • United Kingdom2.06%
  • France1%
  • Germany0.9%
  • Canada0.5%
  • Netherlands0.42%
  • Denmark0.32%
  • Switzerland0.28%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States94.97%
United Kingdom2.06%
France1%
Germany0.9%
Canada0.5%
Netherlands0.42%
Denmark0.32%
Switzerland0.28%
Performance
1 week-4.2%
1 month+3.6%
3 months+3.3%
6 months+20.4%
YTD+23.0%
1 year—
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week+$2M
1 month+$13M
3 months+$44M
YTD+$68M
1 year+$68M

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

Monthly net flows

  • Inflow / above zero
  • Outflow / below zero
+$962.6KSep+$742.3KOct+$26.9MFeb$0Mar−$7.6MApr$0May−$948KJun+$3.6MJul+$13.5MAug+$12.3MSep+$9MOct+$11MNovSepOct+$26.9MFebMarAprMayJunJulAugSepOct+$11MNovSep+$26.9MFebAprJunAug+$11MNov
Source: Daily creation/redemption records, trailing twelve months
Show as table
LabelValue ($)
Sep$962.6K
Oct$742.3K
Feb$26.9M
Mar$0
Apr−$7.6M
May$0
Jun−$948K
Jul$3.6M
Aug$13.5M
Sep$12.3M
Oct$9M
Nov$11M
The risk read
32%realized volatility, 30 days (annualized)
23%realized volatility, 1 year
-9.2%deepest fall from a peak, 1 year
-5.3%latest close versus that peak

The top holding is 9.1% of the book; the top ten carry 48%. Spread across 250+ names, it behaves like roughly 29 equally-weighted positions.

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
—calls · latest snapshot
—puts · latest snapshot
—put/call ratio
38Kshares traded
Most-traded holdings, options premiumBullishBearish
MRNA MODERNA$30M$26M
SMMT SUMMIT THERAPEUTICS$5M$5M
CGON CG ONCOLOGY INC$3M$6M
TEM TEMPUS AI INC$3M$5M
REGN REGENERON PHARMACEUTICALS$4M$2M

TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES

The case against IBBQ

Due diligence cuts both ways. These funds sit on the same shelf and beat IBBQ on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
IVV iShares Core S&P 500 ETF0.03%$879.1B+$10.1B-16bp on fee · 6777× the assets · +$10.1B in over the monthHead-to-head
SPDW SPDR Portfolio Developed World ex-US ETF0.03%$41.6B+$917M-16bp on fee · 321× the assets · +$917M in over the monthHead-to-head
BBUS JPMorgan BetaBuilders U.S. Equity ETF0.02%$9.7B+$356M-17bp on fee · 75× the assets · +$356M in over the monthHead-to-head
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.03%$18.4B+$199M-16bp on fee · 141× the assets · +$199M in over the monthHead-to-head
SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF0.03%$14.2B+$235M-16bp on fee · 110× the assets · +$235M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.

Watch & listen: Invesco

From the manager behind IBBQAll of Watch & Listen
ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.